AR039900A1 - Medicamentos que contienen 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol con liberacion retardada del compuesto activo - Google Patents

Medicamentos que contienen 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol con liberacion retardada del compuesto activo

Info

Publication number
AR039900A1
AR039900A1 ARP030101884A ARP030101884A AR039900A1 AR 039900 A1 AR039900 A1 AR 039900A1 AR P030101884 A ARP030101884 A AR P030101884A AR P030101884 A ARP030101884 A AR P030101884A AR 039900 A1 AR039900 A1 AR 039900A1
Authority
AR
Argentina
Prior art keywords
pentan
phenyl
methyl
release
weight
Prior art date
Application number
ARP030101884A
Other languages
English (en)
Spanish (es)
Inventor
Iris Ziegler
Johannes Bartholomaeus
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR039900A1 publication Critical patent/AR039900A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ARP030101884A 2002-05-29 2003-05-29 Medicamentos que contienen 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol con liberacion retardada del compuesto activo AR039900A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10224108A DE10224108A1 (de) 2002-05-29 2002-05-29 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung

Publications (1)

Publication Number Publication Date
AR039900A1 true AR039900A1 (es) 2005-03-09

Family

ID=29557413

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101884A AR039900A1 (es) 2002-05-29 2003-05-29 Medicamentos que contienen 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol con liberacion retardada del compuesto activo

Country Status (14)

Country Link
EP (1) EP1507519B1 (enExample)
JP (1) JP5459818B2 (enExample)
AR (1) AR039900A1 (enExample)
AT (1) ATE326218T1 (enExample)
AU (1) AU2003238397A1 (enExample)
CA (1) CA2488220C (enExample)
DE (2) DE10224108A1 (enExample)
DK (1) DK1507519T3 (enExample)
ES (1) ES2263976T3 (enExample)
MY (1) MY134311A (enExample)
PE (1) PE20040529A1 (enExample)
PL (1) PL218397B1 (enExample)
PT (1) PT1507519E (enExample)
WO (1) WO2003099267A1 (enExample)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
JPH06172161A (ja) * 1992-12-10 1994-06-21 Shin Etsu Chem Co Ltd 徐放性錠剤
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JPH1017497A (ja) * 1996-07-02 1998-01-20 Takeda Chem Ind Ltd 徐放性製剤およびその製造方法
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Also Published As

Publication number Publication date
DE50303372D1 (de) 2006-06-22
EP1507519A1 (de) 2005-02-23
CA2488220A1 (en) 2003-12-04
JP5459818B2 (ja) 2014-04-02
DK1507519T3 (da) 2006-08-28
ATE326218T1 (de) 2006-06-15
WO2003099267A1 (de) 2003-12-04
PT1507519E (pt) 2006-08-31
PE20040529A1 (es) 2004-08-24
CA2488220C (en) 2011-02-01
EP1507519B1 (de) 2006-05-17
JP2005534640A (ja) 2005-11-17
AU2003238397A1 (en) 2003-12-12
MY134311A (en) 2007-12-31
PL218397B1 (pl) 2014-11-28
DE10224108A1 (de) 2004-01-29
PL374186A1 (en) 2005-10-03
ES2263976T3 (es) 2006-12-16

Similar Documents

Publication Publication Date Title
AR036943A1 (es) Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
ES2690061T3 (es) Composiciones para tratar la enfermedad de Parkinson
AR061771A1 (es) Sistema de administracion terapeutica
CL2016001411A1 (es) Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina.
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
NO20051854L (no) Vedvarende frigivelse opioidformuleringer og fremgangsmater for anvendelse.
PE20040134A1 (es) Forma de dosificacion de una vez al dia de pramipexol
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
ES2733044T1 (es) Composición farmacéutica que contiene oxicodona y naloxona
BRPI0507683A8 (pt) dose unitária de formulação farmacêutica com liberação controlada, seu processo de preparação e uso de um copolímero de poli(acrilato de etila, metacrilato de metila) neutro
CL2010000816A1 (es) Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06)
MX382255B (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
ECSP055788A (es) Sistema de suministro de fármacos
AR062167A1 (es) Sistema de administracion gastrorretentivo
AR044200A1 (es) Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo
AR062647A1 (es) Formulaciones farmaceutica y metodos de uso
PE20091949A1 (es) Formulacion farmaceutica solida con liberacion retardada
AR043822A1 (es) Formas de dosificacion y procedimientos de tratamiento que usan inhibidores del vegfr
SG146638A1 (en) Pharmaceutical delivery system
UY28366A1 (es) Compuestos químicos
ES2194832T3 (es) Formulaciones de ditiazem con absorcion controlada.
NO20080244L (no) Doseringsstyring for prasugrel
AR079000A1 (es) Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas

Legal Events

Date Code Title Description
FB Suspension of granting procedure